Efficacy and Toxicity of Fifth-line Nivolumab in a 15-Year-Old Girl With Metastatic Juvenile Renal Cell Carcinoma

Article de revue

Avec comité de lecture

Tasnime Akbaraly, Magali Saguintaah, Delphine Topart et Nicolas Sirvent

Journal of pediatric hematology/oncology, Vol.40(3), pp.251-252

01/04/2018

PMID: 29420369

Résumé

Adolescent

Antineoplastic Agents, Immunological - therapeutic use

Carcinoma, Renal Cell - drug therapy

Female

Humans

Kidney Neoplasms - drug therapy

Neoplasm Recurrence, Local - drug therapy

Nivolumab - therapeutic use

Salvage Therapy - methods

1 Consultations de la notice

Titre: Efficacy and Toxicity of Fifth-line Nivolumab in a 15-Year-Old Girl With Metastatic Juvenile Renal Cell Carcinoma
Créateurs - sans rôle: Tasnime Akbaraly - Departments of Pediatric Hematology and Oncology
Magali Saguintaah - Pediatric Radiology
Delphine Topart - Medical Oncology, University Hospital of Montpellier, Montpellier, France
Nicolas Sirvent - Departments of Pediatric Hematology and Oncology
Détails de publication: Journal of pediatric hematology/oncology, Vol.40(3), pp.251-252
Identifiants: 99148922309311
Unité académique: Recherche hors université
Langue: English
Type de ressource: Journal article